Mosunetuzumab as salvage therapy for refractory connective tissue diseases: clinical responses and immunological insights.
Annals of the rheumatic diseases
View this publicationAnnals of the rheumatic diseases
View this publicationDie Ophthalmologie
View this publicationUrologie (Heidelberg, Germany)
View this publicationRMD open
View this publicationDie Anaesthesiologie
View this publicationMicrobial cell factories
View this publicationHaemophilia : the official journal of the World Federation of Hemophilia
View this publicationThe Lancet. Microbe
View this publicationNature communications
View this publicationIntensive care medicine experimental
View this publication